April 13, 2026
King & Spalding Secures Significant Win Dismissing 40,000+ Cases for Boehringer Ingelheim in Zantac-Related Litigation in Delaware
July 8, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Trial
April 9, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Retrial
March 31, 2025
King & Spalding Secures Victory for The American Clinical Laboratory Association Challenging a Final Rule Issued by the FDA
March 26, 2025
Heartflow Completes Convertible Notes Financing
February 24, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Retrial
January 7, 2025
King & Spalding Secures Defense Jury Verdict for Johnson & Johnson in Cosmetic Talcum Powder Litigation
August 27, 2024
King & Spalding Secures Summary Judgment Wins for Merck and Organon in Nationwide Litigation
July 8, 2024
King & Spalding advises TVM Capital Healthcare on its $35 million investment into Boston Oncology Arabia
May 23, 2024
King & Spalding Secures Victory for Boehringer Ingelheim in First Zantac-Related Trial
April 18, 2024
King & Spalding Secures Defense Jury Verdict for Johnson & Johnson in Cosmetic Talcum Powder Litigation
February 28, 2024
King & Spalding Secures a Dismissal of False Claims Act Complaint against Senseonics Incorporated